Back
Keros Therapeutics Vs. Repligen Industry Stock Comparison
Sell
41
KROS
Keros Therapeutics
Last Price:
56.56
Seasonality Move:
26.15%
Sell
30
RGEN
Repligen
Last Price:
124.90
Seasonality Move:
7.3%
Sell
41
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $56.62. The Score for KROS is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- KROS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Repligen (RGEN)
is a Sell
Is Repligen a Buy, Sell or Hold?
- The current Repligen [RGEN] share price is $124.73. The Score for RGEN is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- RGEN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $56.62
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight selling pressure.
KROS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.99 | Buy |
Relative Strength Index (14 RSI): | 38.95 | Sell |
Chaikin Money Flow: | -256691 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (58.44 - 64.56) | Sell |
Bollinger Bands (100): | (46.17 - 60.07) | Buy |
RGEN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.46 | Sell |
Relative Strength Index (14 RSI): | 36.22 | Sell |
Chaikin Money Flow: | -1285419 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (134.94 - 146.38) | Sell |
Bollinger Bands (100): | (130 - 153.64) | Sell |
KROS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 64.33 | Sell |
20-day SMA: | 61.68 | Sell |
50-day SMA: | 59.23 | Sell |
200-day SMA: | 55.39 | Buy |
8-day EMA: | 62.03 | Sell |
20-day EMA: | 61.79 | Sell |
50-day EMA: | 58.93 | Sell |
200-day EMA: | 53.14 | Buy |
RGEN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 142.02 | Sell |
20-day SMA: | 140.23 | Sell |
50-day SMA: | 141.19 | Sell |
200-day SMA: | 157.58 | Sell |
8-day EMA: | 139.7 | Sell |
20-day EMA: | 140.54 | Sell |
50-day EMA: | 141.71 | Sell |
200-day EMA: | 151.3 | Sell |
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.57 per share.
Repligen Earnings Growth & RGEN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $0.22 per share.
Keros Therapeutics Technical Analysis
Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Repligen Technical Analysis
Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |